Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData
According to GlobalData, more than 190 million people currently live with type 2 diabetes and/or obesity in 7MM, and the numbers…
Glenmark receives ANDA approval for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution,…
Glenmark’s Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% has been determined by the FDA to be…
Bengaluru Pharma Summit 2024 | 21st June 2024
21st June 2024 | Welcomhotel By ITC, Bengaluru | 2:00 PM - 8:30 PM IST
SII invests in IntegriMedical’s Needle-Free Injection System technology
With this investment, SII will acquire a 20 per cent stake in IntegriMedical. Reportedly, the investment is expected to accelerate…
Zydus, MSN partner to license and supply Cabozantinib Tablets for the US
As per the agreement, MSN will manufacture and supply the generic version of CABOMETYX and Zydus will exclusively market,…
Growth Guardians | Saif Mehkri, Founder & Director, Bio-gen Extracts Pvt. Ltd.
Growth Guardian I Express Pharma – Nutrify Today Boardroom Series | Special Edition
USFDA concludes inspection of Indoco’s Rabale facility
The inspection concluded with zero Form 483 observations
Annapurna Das appointed as the General Manager for Takeda in India
The appointment is effective as of May 16, 2024
Lupin receives USFDA approval for Midostaurin Capsules
Midostaurin Capsules, 25 mg, are indicated to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated…
Growth Guardian I Sanjaya Mariwala, Executive Chairman and Managing Director, OmniActive Health…
Growth Guardian I Express Pharma – Nutrify Today Boardroom Series | Special Edition